RT @Dr_alammar1: هل أستخدم الاسبرين للوقاية من الجلطات مع تقدم العمر؟ دراسة حديثة معتبرة أجريت على ٢٠ألف شخص، أثبتت أنه لم يقي من الجلطات ب…
RT @Dr_alammar1: هل أستخدم الاسبرين للوقاية من الجلطات مع تقدم العمر؟ دراسة حديثة معتبرة أجريت على ٢٠ألف شخص، أثبتت أنه لم يقي من الجلطات ب…
RT @Dr_alammar1: هل أستخدم الاسبرين للوقاية من الجلطات مع تقدم العمر؟ دراسة حديثة معتبرة أجريت على ٢٠ألف شخص، أثبتت أنه لم يقي من الجلطات ب…
RT @IvoVegter: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/COUZy8gDoR (A daily aspirin in otherwise…
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly | NEJM https://t.co/COUZy8gDoR (A daily aspirin in otherwise healthy older people causes more deaths than it prevents. Whoopsie.)
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @HighSTEACS: #ASPREE trial should influence practice. Aspirin in healthy older persons increases all cause mortality (excess cancer deat…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @Dr_alammar1: هل أستخدم الاسبرين للوقاية من الجلطات مع تقدم العمر؟ دراسة حديثة معتبرة أجريت على ٢٠ألف شخص، أثبتت أنه لم يقي من الجلطات ب…
RT @Dr_alammar1: هل أستخدم الاسبرين للوقاية من الجلطات مع تقدم العمر؟ دراسة حديثة معتبرة أجريت على ٢٠ألف شخص، أثبتت أنه لم يقي من الجلطات ب…
هل أستخدم الاسبرين للوقاية من الجلطات مع تقدم العمر؟ دراسة حديثة معتبرة أجريت على ٢٠ألف شخص، أثبتت أنه لم يقي من الجلطات بشكل مؤثر، بالعكس زاد من حالات نزيف الدماغ والمعدة. * هذه الدراسة لاتنطبق على المرضى الذين أخذوا الاسبرين بوصفة. https://t.co/f0zlP3pBU
RT @UrologieParis: Well conducted study with only 8.1% of patients in placebo group who used off-label aspirin at 6 years. ( Table S7 in th…
Maybe not always a good thing - Aspirin increases All-Cause Mortality in Healthy Elderly | NEJM https://t.co/OEwLtUQqmy
RT @cagrimbakirci: 35 yaş sonrasında her gün 1 #aspirin alarak inme gibi kardiyovasküler hastalıkların riskini azaltma düşüncesine en öneml…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @ymori117: NEJM「健康高齢者における全原因死亡へのアスピリンの効果」 https://t.co/vW1JFcCnxG 豪州・米国の心血管リスク・認知症・身体障害を持たない70歳以上の高齢者1万9114名対象、一次予防目的でのアスピリンと偽薬の無作為比較試験。…
'Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death.' https://t.co/4y2acMtT5v
RT @DrHBurstein: In placebo controlled trial of health older individuals, aspirin use doubled risk of overall death, doubled risk of breast…
RT @ymori117: NEJM「健康高齢者における全原因死亡へのアスピリンの効果」 https://t.co/vW1JFcCnxG 豪州・米国の心血管リスク・認知症・身体障害を持たない70歳以上の高齢者1万9114名対象、一次予防目的でのアスピリンと偽薬の無作為比較試験。…
Aspirin "zur Sicherheit" bei älteren Menschen hat nicht nur keinen Vorteil, ist im Gegenteil sogar schädlich. @NEJM https://t.co/LYiNvtBhkU
RT @jjkiladjian: 3 études avec absence de bénéfice voire effet délétère de l'aspirine dans la population âgée en général : urgence à complé…
RT @ErinMichos: #ASPREE: Higher risk of all-cause mortality seen for #aspirin compared to placebo HR 1.14 (1.01-1.29). Mortality excess not…
@cetinerm hocam dün sizin aspirin videosundan sonra ikilemde bırakıyor
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @TroKalayjian: Cardiologists got screwed this week👇🏻👇🏻 ❌Effect of ASA on Mortality in Elderly https://t.co/JmNXUrOxsG ❌Effect of ASA o…
RT @Gilvernet: Evidencias que no aconsejan el uso de aspirina en individuos sanos. La mortalidad por cáncer fue 1,6 veces mayor en el grupo…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @whyes: 这个研究有些毁三观。大规模(近两万人)的随机对照研究发现,对于相对健康的老年人,每天1粒拜阿司匹林不能提供心血管病方面的益处,反而增加了大出血的风险,并且稍稍增加了死亡率。最接受不了的结果在于,阿司匹林反而增加了癌症相关的死亡率,风险上升30%左右。 ht…
Resultado inesperado: mayor mortalidad por todas las causas entre los adultos sanos que recibieron aspirina que entre los que recibieron placebo y se atribuyó principalmente a la muerte relacionada con el cáncer. https://t.co/JnFDB2qqGW
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
RT @AndersPerner: First do no harm. Publicly-funded academic trials again and again show that less is often better to the benefit of patien…
RT @ozlemyildiz1881: Aspirinin artmış kanser riski ile ilişkili bulunması yeni bir bulgu ve doğrulanmaya muhtaç. Ancak, zaten, kardiyovaskü…
RT @drmiguelmarcos: Tomar 100 mg de aspirina en personas >67-70 no supuso una mejora en su estado de salud y causó más hemorragias. Un ejem…
RT @Bloodman: @HeidiKJ And more evidence for that in today NEJM (but ASA still rocks for secondary prevention) https://t.co/PpnsEEUHcC
Evidencias que no aconsejan el uso de aspirina en individuos sanos. La mortalidad por cáncer fue 1,6 veces mayor en el grupo que tomó AAS, siendo del 3,1% en el grupo de aspirina frente a un 2,3% en el grupo placebo.
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
Aspirinin artmış kanser riski ile ilişkili bulunması yeni bir bulgu ve doğrulanmaya muhtaç. Ancak, zaten, kardiyovasküler hastalığı olmayanlarda, aspirinle ilişkili kanama komplikasyonu yararını aştığı için, rutinde sadece sekonder korumada önerilmekteydi.
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @jjkiladjian: 3 études avec absence de bénéfice voire effet délétère de l'aspirine dans la population âgée en général : urgence à complé…
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
RT @mlalanda: Os acordais cuando dábamos aspirina en dosis baja a las personas mayores de forma profiláctica...? https://t.co/002AEci40c
RT @drmiguelmarcos: Tomar 100 mg de aspirina en personas >67-70 no supuso una mejora en su estado de salud y causó más hemorragias. Un ejem…
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
Looks like aspirin is not the panacea we once thought for healthy adults over 70yo... https://t.co/6FlJfQ2bvC
RT @drmiguelmarcos: Tomar 100 mg de aspirina en personas >67-70 no supuso una mejora en su estado de salud y causó más hemorragias. Un ejem…
RT @J_C_MD_PhD: Primaire preventie van hart-vaatziekten bij gezonde ouderen door aspirine: geen baat, wel schade. https://t.co/jMb4m0WdR2
Surrisque de décès de 1,6 par cancer sous 100mg/j. Inattendu ! On attendait le contraire chez les plus de 70 ans. Les auteurs conseillent de prendre le résultat avec précaution. A lire en libre accès. https://t.co/nVSxHeIbqc
RT @drmiguelmarcos: Tomar 100 mg de aspirina en personas >67-70 no supuso una mejora en su estado de salud y causó más hemorragias. Un ejem…
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
Gerçekten hassas bir konu. Tıp Doktorlarını da dinlemek lazım. @omerdonderici
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
RT @AndersPerner: First do no harm. Publicly-funded academic trials again and again show that less is often better to the benefit of patien…
RT @gantaisaku1105: 《短報》 心血管疾患、認知症、身体障害のない70歳以上の健康な人が「アスピリン」を5年間毎日飲んでも健康寿命が伸びないばかりか、がんによる死亡率が高まる。〔NEJM〕 https://t.co/cNGw3eT1CU https://t.c…
If true, these studies are massive bombshells... increased (GI) cancer-specific mortality AND major hemorrhage without concomitant decrease in cardiovascular mortality?? I just graduated med school 4 months ago and my knowledge is already obsolete...
RT @dytbuketmamur: Görür görmez çalışmaya tıklayıp aspirin kullanan eşime hızla tarayarak okudum. Sonra gördüm ki devam twitlerinde zaten ö…
Higher mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death. https://t.co/dHXvluaycs
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
Valla babam bildim bileli hep gün aşırı aspirin içerdi. Şimdi 85 yaşında ve ne kalp rahatsızlığı, ne tansiyon, ne şeker hiç öyle sıkıntıları yok. Bir iki farklı rahatsızlığı var yalnızca, o da sadece yaşam kalitesini düşürüyor o kadar. Science rocks.
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @Aiims1742: Before the "ASPIRIN CAUSES CANCER" headlines hit the news based on today's @NEJM study in elderly patients (mostly >70y) htt…
(iii) Primary #prevention with 100 mg #Asirin does *not* decrease #mortality but rather increases #cancer-related #death. #ASPREE https://t.co/bFBGQ4uvLj https://t.co/bFBGQ4uvLj
RT @HighSTEACS: #ASPREE trial should influence practice. Aspirin in healthy older persons increases all cause mortality (excess cancer deat…
RT @Bloodman: Worrisome - aspirin increased all cause mortality in health older folks! https://t.co/zmwrmEp9yB
RT @MrJeffKarp: WoW! from NEJM!! "Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin…
RT @MarcGozlan: Selon une étude dans @NEJM, les sujets âgés en bonne santé ≥ 70 ans qui n'ont pas d'indication à être sous aspirine mais qu…
RT @SBurtey: Prendre de l'aspirine quand on est vieux et en bonne santé augmente la mortalité et le risque de saigner sans aucun bénéfice…
RT @mlalanda: Os acordais cuando dábamos aspirina en dosis baja a las personas mayores de forma profiláctica...? https://t.co/002AEci40c
RT @Bloodman: Worrisome - aspirin increased all cause mortality in health older folks! https://t.co/zmwrmEp9yB
Pas d’aspirine chez sujet âge en bonne santé augmentation mortalité et hémorragie ! #prevention
RT @drmiguelmarcos: Tomar 100 mg de aspirina en personas >67-70 no supuso una mejora en su estado de salud y causó más hemorragias. Un ejem…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @drmiguelmarcos: Tomar 100 mg de aspirina en personas >67-70 no supuso una mejora en su estado de salud y causó más hemorragias. Un ejem…
RT @LoebStacy: #Cancer was the major contributor to the higher mortality in the #aspirin group, accounting for 1.6 excess deaths per 1000 p…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
There were 1.6 more deaths per 1000 person-years among healthy older adults who were randomly assigned to receive aspirin than among those who received placebo. Cancer-related death accounted for much of the excess mortality. https://t.co/sl2WfAea36
RT @AndersPerner: First do no harm. Publicly-funded academic trials again and again show that less is often better to the benefit of patien…
Astonishing!
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @MarcGozlan: Selon une étude dans @NEJM, les sujets âgés en bonne santé ≥ 70 ans qui n'ont pas d'indication à être sous aspirine mais qu…
RT @TKDsosyal: ASCEND, ARRIVE and now ASPREE. In patients w/o CVD, dementia and physical disability daily ASA 100 mg did not ⬇️ comp. prim…
RT @Chris_Barbieri1: Yikes - didn't see this one coming. Increased cancer deaths with aspirin. I have no idea how to interpret that. http…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
RT @jjkiladjian: 3 études avec absence de bénéfice voire effet délétère de l'aspirine dans la population âgée en général : urgence à complé…
RT @AndersPerner: First do no harm. Publicly-funded academic trials again and again show that less is often better to the benefit of patien…
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
Pretty extraordinary. When I think of the vol of enteric 300mg that have been dished out in pharmacies in Europe over the last few decades.....
RT @ozvascdoc: It was a long time coming, but aspirin for primary prevention in patients >70yo is out. #ASPREE. https://t.co/rCGtWNNrOC
RT @LoebStacy: #Cancer was the major contributor to the higher mortality in the #aspirin group, accounting for 1.6 excess deaths per 1000 p…
RT @AndyBiotech: Whoa, new data from N=19,114 ASPREE trial found low-dose aspirin no effect on healthy life span in older ppl https://t.co/…
‘Among healthy adults who did not have an indication for aspirin use and were predominantly 70 years of age or older at enrollment, all-cause mortality was apparently higher among those who received daily low-dose aspirin’ https://t.co/AD8LX4Bbwx
RT @NEJM: Original Article: Effect of #Aspirin on All-Cause Mortality in the Healthy Elderly (ASPREE) https://t.co/Cn2Ot9f1ka https://t.co/…
WoW! from NEJM!! "Higher all-cause mortality was observed among apparently healthy older adults who received daily aspirin than among those who received placebo and was attributed primarily to cancer-related death." https://t.co/KHjq1RZBf2
RT @AndyBiotech: Whoa, new data from N=19,114 ASPREE trial found low-dose aspirin no effect on healthy life span in older ppl https://t.co/…
RT @EstebanDL: Personas sanas mayores de 65 años Aspirina 100 mg vs placebo Aumento de mortalidad en el grupo Aspirina https://t.co/En28bAU…
RT @ozvascdoc: It was a long time coming, but aspirin for primary prevention in patients >70yo is out. #ASPREE. https://t.co/rCGtWNNrOC